Chris Hansen is the founder of Long-Short Equity investor, Valiant Capital. We cover his investing journey so far, the complexities and challenges of short selling, and how private markets are evolving.

John Crowley is the CEO of the Biotechnology Innovation Organization. We cover the inspirational story of his search to find a cure for the deadly Pompe disease, what he learned about leadership by serving in the military, and what every investor should know about biotech.

Daniel Eisen and Paul Yancich are the co-founders of Arcadea Group. We cover their time at Constellation Software and other formative experiences, how they define and look for high-quality growth companies, and the value of a stable, long-term oriented capital base.

Katie Koch is the President and CEO of the TCW Group. We cover the formative experiences that helped her not to fear failure, why resilience and humility are such essential qualities in leaders, and the biggest lessons from leading the investment team at TCW.

Oliver Thomas is the Founder and Managing Partner of Expedition Growth Capital. We cover the formative experiences in his education and early career, how he built a business from the idea of bootstrap investing, and what advice he'd give to aspiring builders of investment firms.

Iris Rubin and Greg Maged are co-founders of SEEN. We cover the mission they chose to build a business around, what the intersection of science and product development looks like, and why anyone with an idea should find a co-founder to cultivate a partnership with.

André Perold is the co-founder of HighVista Strategies and Professor Emeritus at Harvard Business School. We cover his life's path through teaching and investing, how to think about compounding in daily life, and why you should always invest in human capital and relationships.

David Glynn is joined by Patrick O'Shaughnessy alongside Rick and Paul to honor the life & career of his father, John Glynn. John was a legendary investor, teacher, leader, father, and husband. His legacy is survived by Glynn Capital, an arbiter of mega-trends in technology.

Cal Fussman is a legendary journalist. We cover where his passion for asking questions came from, what it's like to interview the world's most extraordinary figures, and how to get better at making human connections.

Jeff Marrazzo is the Co-Founder of Spark Therapeutics. We cover the uncommon sources of inspiration that led to the founding of Spark, how it has the potential to revolutionize gene therapy, and lessons learned from navigating the complex world of FDA approval.